LB Pharmaceuticals Inc Common Stock (LBRX) is a publicly traded the market company. As of September 3, 2026, LBRX trades at $47.41 with a market cap of $1.52B and a P/E ratio of -15.64. LBRX moved +0.00% today. Year to date, LBRX is +142.07%; over the trailing twelve months it is flat. Its 52-week range spans $13.36 to $50.16. Analyst consensus is strong buy with an average price target of $56.57. Rallies surfaces LBRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for LBRX, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $47.41 |
| Market Cap | $1.52B |
| P/E Ratio | -15.64 |
| EPS | $-3.13 |
| Dividend Yield | 0.00% |
| 52-Week High | $50.16 |
| 52-Week Low | $13.36 |
| Volume | 70.27K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-25.20M |
| Gross Margin | 0.00% |
7 analysts cover LBRX: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $56.57.